Hepatitis B therapeutics are treatment approaches used to control viral infection and prevent liver-related complications. These therapies aim to lower viral load in the body. They play a key role in chronic hepatitis management. Hepatitis B Therapeutics Market Overview The Hepatitis B Therapeutics Market is projected to reach US$ 7.26 billion by 2031, growing at a CAGR of 8.8%...